| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 246.198 | 219.875 | 211.441 | 178.177 | 178.964 | 195.450 | 202.095 | 196.582 | 196.855 | 190.269 |
| Total Income - EUR | 246.908 | 229.578 | 211.490 | 179.086 | 195.330 | 197.432 | 203.504 | 198.394 | 197.161 | 194.623 |
| Total Expenses - EUR | 241.885 | 212.428 | 222.163 | 188.897 | 188.471 | 197.668 | 214.163 | 193.878 | 198.094 | 197.000 |
| Gross Profit/Loss - EUR | 5.023 | 17.151 | -10.673 | -9.811 | 6.859 | -237 | -10.660 | 4.517 | -933 | -2.377 |
| Net Profit/Loss - EUR | 2.831 | 13.731 | -12.987 | -11.658 | 4.887 | -1.711 | -12.698 | 2.516 | -2.915 | -2.470 |
| Employees | 2 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
Check the financial reports for the company - Calendula Pharm Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 7.857 | 4.731 | 2.746 | 809 | 502 | 207 | 35 | 35 | 35 | 34 |
| Current Assets | 117.659 | 93.581 | 78.370 | 64.282 | 63.065 | 71.779 | 59.371 | 61.546 | 52.049 | 38.996 |
| Inventories | 19.476 | 21.924 | 28.860 | 16.110 | 30.406 | 27.865 | 20.836 | 21.806 | 19.928 | 18.299 |
| Receivables | 45.591 | 12.776 | 26.684 | 32.872 | 26.512 | 39.132 | 34.006 | 34.644 | 26.906 | 19.310 |
| Cash | 52.592 | 58.881 | 22.826 | 15.300 | 6.147 | 4.782 | 4.529 | 5.096 | 5.215 | 1.387 |
| Shareholders Funds | 57.898 | 15.735 | 2.482 | -9.221 | -4.156 | -5.787 | -18.357 | -15.898 | -18.765 | -21.130 |
| Social Capital | 1.125 | 1.113 | 1.095 | 1.074 | 1.054 | 1.034 | 1.011 | 1.014 | 1.011 | 1.005 |
| Debts | 68.575 | 82.577 | 78.635 | 74.313 | 67.723 | 77.773 | 77.763 | 77.479 | 70.848 | 60.160 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Calendula Pharm Srl